SMO is a molecular target of the teratogen cyclopamine and has also been shown to bind to actin Costal-2 and play a role in the localization of the Ci complex. Studies have shown that SMO can act as a proto-oncogene, and activation of SMO mutations can lead to activation of the unregulated hedgehog pathway.